Capillaritis: Treatment and Differential Diagnoses
Capillaritis requires immediate evaluation to distinguish between cutaneous (pigmented purpuric dermatoses) and life-threatening pulmonary forms, with treatment ranging from observation for benign skin variants to aggressive immunosuppression with corticosteroids and cyclophosphamide for systemic vasculitis-associated pulmonary capillaritis.
Critical Initial Distinction
The term "capillaritis" encompasses two fundamentally different entities that require vastly different management approaches:
1. Cutaneous Capillaritis (Pigmented Purpuric Dermatoses)
- Benign, self-limited skin condition
- Presents as hyperpigmented patches or purpuric lesions
- Can present in rare variants like unilateral linear capillaritis 1
- Treatment: Generally observation only; topical corticosteroids may be used for symptomatic relief
2. Pulmonary Capillaritis
- Life-threatening condition requiring urgent intervention
- Presents with diffuse alveolar hemorrhage (DAH), dyspnea, hemoptysis (though often absent), bilateral infiltrates on imaging, and progressive anemia 2, 3
- Treatment: Aggressive immunosuppression is mandatory
Differential Diagnoses for Pulmonary Capillaritis
The overwhelming majority of pulmonary capillaritis cases are secondary to systemic autoimmune diseases 4. The differential diagnosis includes:
Primary Vasculitides (Most Common):
Secondary Causes:
- Systemic lupus erythematosus (with or without capillaritis) 2, 3
- Drug-induced (particularly propylthiouracil and other antithyroid drugs) 2
- IgA nephropathy/Henoch-Schönlein purpura 3, 5
- Antiphospholipid syndrome 3
- Behçet's syndrome 3
- Progressive systemic sclerosis 3
- Rheumatoid arthritis 5
Rare Entity:
- Isolated pulmonary capillaritis (IPC): Pulmonary capillaritis without systemic disease - extremely rare with only 4 cases identified in a 17-year cohort 4
Diagnostic Workup Algorithm
When pulmonary capillaritis is suspected:
Confirm DAH: Bronchoalveolar lavage retrieving bright red fluid is the best diagnostic clue 2
Mandatory serologic testing:
Histopathologic confirmation:
Exclude infection aggressively before initiating immunosuppression 2, 3
Treatment Approach for Pulmonary Capillaritis
Treatment targets the underlying systemic disorder and follows this general framework:
Acute/Severe DAH:
- Corticosteroids: High-dose (methylprednisolone 1-2 mg/kg IV) 2
- Cyclophosphamide as primary immunosuppressant 2, 3
- Plasma exchange: Particularly in severe DAH, this is standard practice despite awaiting definitive evidence 2
- Exclude infection before and during immunosuppression 6, 3
Maintenance Therapy:
- Corticosteroids with cyclophosphamide or azathioprine 2, 3
- Duration and intensity depend on underlying disease
Isolated Pulmonary Capillaritis:
- Despite rarity, responds well to immunosuppression 4
- Most patients achieve remission with benign clinical course 4
- Median follow-up of 116.5 months showed no development of systemic disease 4
Critical Pitfalls to Avoid
- Hemoptysis is often absent - don't wait for it to diagnose DAH 2
- Progressive anemia without obvious bleeding source should trigger consideration of DAH 2
- Delay in diagnosis is common - maintain high index of suspicion with bilateral infiltrates and unexplained anemia 4
- Infection must be excluded before starting immunosuppression, as these patients will receive aggressive immunosuppressive therapy 6, 3
- Histologic findings alone cannot subclassify most cases - requires integration with clinical data, serology, and kidney biopsy when indicated 5